Humoral and Cellular Responses to BNT162b2 as a Booster Following Two Doses of ChAdOx1 nCov-19 Determined Using Three SARS-CoV-2 Antibody Assays and an Interferon-Gamma Release Assay: A Prospective Longitudinal Study in Healthcare Workers

Data on humoral and cellular responses to BNT162b2 as a booster dose, following two doses of ChAdOx1 nCov-19 vaccine, have seldom been reported. The aim of this study was to assess the positivity rates of three representative antibody assays targeting total, IgG, and neutralizing antibodies, and an...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Seri, Lee, Nuri, Lee, Su Kyung, Cho, Eun-Jung, Hyun, Jungwon, Park, Min-Jeong, Song, Wonkeun, Kim, Hyun Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198331/
https://www.ncbi.nlm.nih.gov/pubmed/35720318
http://dx.doi.org/10.3389/fimmu.2022.859019

Ejemplares similares

Ejemplares similares